PainChek

PainChek Net Debt

The Net Debt of PainChek (PCK.AX) as of Nov 11, 2026 is -1.74 M AUD. In the previous year, Net Debt was -1.62 M AUD — a change of 7.77% (lower).

Net Debt

-1.74 MAUD

YoY

7.77%

Last updated:

Net Debt of PainChek is 2026 -1.74 M AUD. Net Debt of PainChek was 2025 -1.62 M AUD. It decreases by 7.77% lower compared to the previous year.

The PainChek Net Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt
Date
Net Debt
Jan 1, 2019
-4.54 M AUD
Jan 1, 2020
-4.87 M AUD
Jan 1, 2021
-10.37 M AUD
Jan 1, 2022
-6.14 M AUD
Jan 1, 2023
-1.76 M AUD
Jan 1, 2024
-3.45 M AUD
Jan 1, 2025
-1.62 M AUD
Jan 1, 2026
-1.74 M AUD
The PainChek Net Debt history
YEARNet DebtYoY
-1.74 MAUD+7.77%
-1.62 MAUD-53.06%
-3.45 MAUD+96.28%
-1.76 MAUD-71.42%
-6.14 MAUD-40.80%
-10.37 MAUD+113.02%
-4.87 MAUD+7.21%
-4.54 MAUD+26.23%
-3.60 MAUD+36.83%
-2.63 MAUD-492.64%
669,823.00AUD+384.50%
138,251.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PainChek Stock analysis

What does PainChek do? PainChek Ltd. develops and commercializes mobile medical device applications, focusing on pain assessment for individuals unable to communicate with carers. The PainChek Universal combines the PainChek Application with the numerical rating scale (NRS), using artificial intelligence and facial recognition to detect pain in non-verbal patients. It provides a point-of-care solution that offers objectivity and consistency in pain assessments, supporting both non-verbal and self-reporting individuals through integrated tools. Healthcare providers and care facilities purchase PainChek Universal to enhance pain management protocols for patients with communication difficulties. The PainChek Application utilizes artificial intelligence and facial recognition technology to assess pain without relying on patient self-reporting, making it suitable for those with cognitive or physical impairments. PainChek Universal integrates the NRS for patients who can self-report, ensuring a comprehensive approach to pain evaluation across varying patient capabilities. This dual functionality allows healthcare professionals to apply consistent assessment standards regardless of a patient's ability to communicate. PainChek Ltd. generates revenue through the commercialization of its mobile medical device applications, specifically targeting healthcare providers and care facilities that require standardized pain assessment tools. The company’s products are designed to address the needs of patients who cannot communicate pain, thereby filling a critical gap in healthcare services. By offering a unified solution that combines AI-driven detection with traditional rating scales, PainChek Universal meets the demands of modern healthcare environments seeking objective and reliable pain management solutions. PainChek is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PainChek stock

Net Debt of PainChek is -1.74 M AUD in 2026.

Net Debt of PainChek changed from -1.62 M AUD to -1.74 M AUD, representing a 7.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt PainChek since 2006 – with annual values, charts, and detailed analysis.

Net debt is total debt minus cash and cash equivalents. It shows the actual debt burden after accounting for available liquid resources.

Net Debt's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Debt's PainChek historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — PainChek

All Key Metrics — PainChek